These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11058637)

  • 1. Nondiffuse fatty change of the liver: discerning pseudotumor on MR images enhanced with ferumoxides-initial observations.
    Hirohashi S; Ueda K; Uchida H; Ono W; Takahama J; Takewa M; Kitano S; Ohishi H
    Radiology; 2000 Nov; 217(2):415-20. PubMed ID: 11058637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging.
    Paley MR; Mergo PJ; Torres GM; Ros PR
    AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM; Kim CS; Youk JH; Lee MS
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging.
    Van Beers BE; Lacrosse M; Jamart J; Grandin C; Gigot JF; Horsmans Y; Demeure R; Pringot J
    AJR Am J Roentgenol; 1997 Mar; 168(3):713-7. PubMed ID: 9057521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
    Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T
    Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
    Goshima S; Kanematsu M; Matsuo M; Kondo H; Kato H; Yokoyama R; Hoshi H; Moriyama N
    J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
    del Frate C; Bazzocchi M; Mortele KJ; Zuiani C; Londero V; Como G; Zanardi R; Ros PR
    Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.
    Arbab AS; Ichikawa T; Sou H; Araki T; Nakajima H; Ishigame K; Yoshikawa T; Kumagai H
    Radiology; 2002 Oct; 225(1):151-8. PubMed ID: 12354999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging.
    Mori K; Scheidler J; Helmberger T; Holzknecht N; Schauer R; Schirren CA; Bittmann I; Dugas M; Reiser M
    AJR Am J Roentgenol; 2002 Oct; 179(4):1045-51. PubMed ID: 12239063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.
    Bluemke DA; Paulson EK; Choti MA; DeSena S; Clavien PA
    AJR Am J Roentgenol; 2000 Dec; 175(6):1653-8. PubMed ID: 11090399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
    Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced mr imaging versus combined helical CT during arterial portography and CT hepatic arteriography.
    Choi D; Kim S; Lim J; Lee W; Jang H; Lee S; Lim H
    AJR Am J Roentgenol; 2001 Feb; 176(2):475-82. PubMed ID: 11159099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases.
    Del Frate C; Zuiani C; Londero V; Como G; Bazzocchi M; Mortele K; Ros PR
    AJR Am J Roentgenol; 2003 May; 180(5):1339-46. PubMed ID: 12704048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
    Ros PR; Freeny PC; Harms SE; Seltzer SE; Davis PL; Chan TW; Stillman AE; Muroff LR; Runge VM; Nissenbaum MA
    Radiology; 1995 Aug; 196(2):481-8. PubMed ID: 7617864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT.
    Kondo H; Kanematsu M; Hoshi H; Murakami T; Kim T; Hori M; Matsuo M; Nakamura H
    AJR Am J Roentgenol; 2000 Apr; 174(4):947-54. PubMed ID: 10749228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography.
    Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM
    Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
    Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA
    AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences.
    Precetti-Morel S; Bellin MF; Ghebontni L; Zaïm S; Opolon P; Poynard T; Mathurin P; Cluzel P
    Eur Radiol; 1999; 9(8):1535-42. PubMed ID: 10525860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.